Robotic Surgical Systems Devices Market

ID: MRFR/MED/14596-HCR 128 Pages Vikita Thakur Last Updated: September 15, 2026
Robotic Surgical Systems Devices Market Research Report Information By Component (Systems, Accessories, and Services), By Surgery Type (Gynecology Surgery, Urology Surgery, Neurosurgery, Orthopedic Surgery, General Surgery, and Other Surgeries) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Market Forecast Till 2035
Robotic Surgical Systems Devices Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)16.0%
2024 Market Size$ 3.77 Billion
2025 Market Size$ 4.37 Billion
2035 Market Size$ 19.29 Billion
Key Players
Intuitive Surgical
Medtronic
Stryker
Johnson & Johnson
Zimmer Biomet
Mazor Robotics
Opportunities
  • Regulatory Support and Standardization
  • Technological Advancements in Robotics
  • Growing Awareness and Training Programs
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Component (USD Billion)
      1. 4.1.1 Systems
      2. 4.1.2 Accessories
      3. 4.1.3 Services
    2. 4.2 Healthcare, BY Surgery Type (USD Billion)
      1. 4.2.1 Gynecology Surgery
      2. 4.2.2 Urology Surgery
      3. 4.2.3 Neurosurgery
      4. 4.2.4 Orthopedic Surgery
      5. 4.2.5 General Surgery
      6. 4.2.6 Other Surgeries
    3. 4.3 Healthcare, BY Region (USD Billion)
      1. 4.3.1 North America
        1. 4.3.1.1 US
        2. 4.3.1.2 Canada
      2. 4.3.2 Europe
        1. 4.3.2.1 Germany
        2. 4.3.2.2 UK
        3. 4.3.2.3 France
        4. 4.3.2.4 Russia
        5. 4.3.2.5 Italy
        6. 4.3.2.6 Spain
        7. 4.3.2.7 Rest of Europe
      3. 4.3.3 APAC
        1. 4.3.3.1 China
        2. 4.3.3.2 India
        3. 4.3.3.3 Japan
        4. 4.3.3.4 South Korea
        5. 4.3.3.5 Malaysia
        6. 4.3.3.6 Thailand
        7. 4.3.3.7 Indonesia
        8. 4.3.3.8 Rest of APAC
      4. 4.3.4 South America
        1. 4.3.4.1 Brazil
        2. 4.3.4.2 Mexico
        3. 4.3.4.3 Argentina
        4. 4.3.4.4 Rest of South America
      5. 4.3.5 MEA
        1. 4.3.5.1 GCC Countries
        2. 4.3.5.2 South Africa
        3. 4.3.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Intuitive Surgical (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Medtronic (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Stryker (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Johnson & Johnson (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Zimmer Biomet (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Mazor Robotics (IL)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 TransEnterix (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Corindus Vascular Robotics (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Surgical Science (SE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY COMPONENT
    4. 6.4 US MARKET ANALYSIS BY SURGERY TYPE
    5. 6.5 CANADA MARKET ANALYSIS BY COMPONENT
    6. 6.6 CANADA MARKET ANALYSIS BY SURGERY TYPE
    7. 6.7 EUROPE MARKET ANALYSIS
    8. 6.8 GERMANY MARKET ANALYSIS BY COMPONENT
    9. 6.9 GERMANY MARKET ANALYSIS BY SURGERY TYPE
    10. 6.10 UK MARKET ANALYSIS BY COMPONENT
    11. 6.11 UK MARKET ANALYSIS BY SURGERY TYPE
    12. 6.12 FRANCE MARKET ANALYSIS BY COMPONENT
    13. 6.13 FRANCE MARKET ANALYSIS BY SURGERY TYPE
    14. 6.14 RUSSIA MARKET ANALYSIS BY COMPONENT
    15. 6.15 RUSSIA MARKET ANALYSIS BY SURGERY TYPE
    16. 6.16 ITALY MARKET ANALYSIS BY COMPONENT
    17. 6.17 ITALY MARKET ANALYSIS BY SURGERY TYPE
    18. 6.18 SPAIN MARKET ANALYSIS BY COMPONENT
    19. 6.19 SPAIN MARKET ANALYSIS BY SURGERY TYPE
    20. 6.20 REST OF EUROPE MARKET ANALYSIS BY COMPONENT
    21. 6.21 REST OF EUROPE MARKET ANALYSIS BY SURGERY TYPE
    22. 6.22 APAC MARKET ANALYSIS
    23. 6.23 CHINA MARKET ANALYSIS BY COMPONENT
    24. 6.24 CHINA MARKET ANALYSIS BY SURGERY TYPE
    25. 6.25 INDIA MARKET ANALYSIS BY COMPONENT
    26. 6.26 INDIA MARKET ANALYSIS BY SURGERY TYPE
    27. 6.27 JAPAN MARKET ANALYSIS BY COMPONENT
    28. 6.28 JAPAN MARKET ANALYSIS BY SURGERY TYPE
    29. 6.29 SOUTH KOREA MARKET ANALYSIS BY COMPONENT
    30. 6.30 SOUTH KOREA MARKET ANALYSIS BY SURGERY TYPE
    31. 6.31 MALAYSIA MARKET ANALYSIS BY COMPONENT
    32. 6.32 MALAYSIA MARKET ANALYSIS BY SURGERY TYPE
    33. 6.33 THAILAND MARKET ANALYSIS BY COMPONENT
    34. 6.34 THAILAND MARKET ANALYSIS BY SURGERY TYPE
    35. 6.35 INDONESIA MARKET ANALYSIS BY COMPONENT
    36. 6.36 INDONESIA MARKET ANALYSIS BY SURGERY TYPE
    37. 6.37 REST OF APAC MARKET ANALYSIS BY COMPONENT
    38. 6.38 REST OF APAC MARKET ANALYSIS BY SURGERY TYPE
    39. 6.39 SOUTH AMERICA MARKET ANALYSIS
    40. 6.40 BRAZIL MARKET ANALYSIS BY COMPONENT
    41. 6.41 BRAZIL MARKET ANALYSIS BY SURGERY TYPE
    42. 6.42 MEXICO MARKET ANALYSIS BY COMPONENT
    43. 6.43 MEXICO MARKET ANALYSIS BY SURGERY TYPE
    44. 6.44 ARGENTINA MARKET ANALYSIS BY COMPONENT
    45. 6.45 ARGENTINA MARKET ANALYSIS BY SURGERY TYPE
    46. 6.46 REST OF SOUTH AMERICA MARKET ANALYSIS BY COMPONENT
    47. 6.47 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGERY TYPE
    48. 6.48 MEA MARKET ANALYSIS
    49. 6.49 GCC COUNTRIES MARKET ANALYSIS BY COMPONENT
    50. 6.50 GCC COUNTRIES MARKET ANALYSIS BY SURGERY TYPE
    51. 6.51 SOUTH AFRICA MARKET ANALYSIS BY COMPONENT
    52. 6.52 SOUTH AFRICA MARKET ANALYSIS BY SURGERY TYPE
    53. 6.53 REST OF MEA MARKET ANALYSIS BY COMPONENT
    54. 6.54 REST OF MEA MARKET ANALYSIS BY SURGERY TYPE
    55. 6.55 KEY BUYING CRITERIA OF HEALTHCARE
    56. 6.56 RESEARCH PROCESS OF MRFR
    57. 6.57 DRO ANALYSIS OF HEALTHCARE
    58. 6.58 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    59. 6.59 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    60. 6.60 SUPPLY / VALUE CHAIN: HEALTHCARE
    61. 6.61 HEALTHCARE, BY COMPONENT, 2024 (% SHARE)
    62. 6.62 HEALTHCARE, BY COMPONENT, 2024 TO 2035 (USD Billion)
    63. 6.63 HEALTHCARE, BY SURGERY TYPE, 2024 (% SHARE)
    64. 6.64 HEALTHCARE, BY SURGERY TYPE, 2024 TO 2035 (USD Billion)
    65. 6.65 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.2.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.3.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.4.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.5.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.6.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.7.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.8.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.9.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.10.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.11.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.12.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.13.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.14.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.15.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.16.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.17.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.18.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.19.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.20.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.21.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.22.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.23.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.24.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.25.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.26.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.27.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.28.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.29.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY COMPONENT, 2025-2035 (USD Billion)
      2. 7.30.2 BY SURGERY TYPE, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Robotic Surgical Systems Devices Market Segmentation

Robotic Surgical Systems Devices Market By Component (USD Billion, 2025-2035)

  • Systems
  • Accessories
  • Robotic Surgical Systems Devices Markets

Robotic Surgical Systems Devices Market By Surgery Type (USD Billion, 2025-2035)

  • Gynecology Surgery
  • Urology Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • General Surgery
  • Other Surgeries
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.